JPS6224423B2 - - Google Patents

Info

Publication number
JPS6224423B2
JPS6224423B2 JP59239607A JP23960784A JPS6224423B2 JP S6224423 B2 JPS6224423 B2 JP S6224423B2 JP 59239607 A JP59239607 A JP 59239607A JP 23960784 A JP23960784 A JP 23960784A JP S6224423 B2 JPS6224423 B2 JP S6224423B2
Authority
JP
Japan
Prior art keywords
group
dihydropyridine
formula
derivative
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP59239607A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60123470A (ja
Inventor
Gurosuman Harutomuuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS60123470A publication Critical patent/JPS60123470A/ja
Publication of JPS6224423B2 publication Critical patent/JPS6224423B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Quinoline Compounds (AREA)
JP59239607A 1983-11-19 1984-11-15 沃素―１２５により標識された１，４―ジヒドロピリジン誘導体及び１，４―ジヒドロキノリン誘導体、その製造及びその用途 Granted JPS60123470A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3341806.3 1983-11-19
DE3341806A DE3341806C2 (de) 1983-11-19 1983-11-19 Radioaktiv mit ↑1↑↑2↑↑5↑I-markierte 1,4-Dihydropyridinderivate und 1,4-Dihydrochinolinderivate, ihre Herstellung und ihre Verwendung zur Ausprüfung von Arzneimitteln

Publications (2)

Publication Number Publication Date
JPS60123470A JPS60123470A (ja) 1985-07-02
JPS6224423B2 true JPS6224423B2 (2) 1987-05-28

Family

ID=6214700

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59239607A Granted JPS60123470A (ja) 1983-11-19 1984-11-15 沃素―１２５により標識された１，４―ジヒドロピリジン誘導体及び１，４―ジヒドロキノリン誘導体、その製造及びその用途

Country Status (5)

Country Link
US (1) US4784958A (2)
JP (1) JPS60123470A (2)
DE (1) DE3341806C2 (2)
FR (1) FR2555175B1 (2)
GB (1) GB2150137B (2)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63162409U (2) * 1987-04-13 1988-10-24
JPH0476212U (2) * 1990-11-16 1992-07-03

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3600593A1 (de) * 1986-01-11 1987-07-16 Bayer Ag (pfeil hoch)3(pfeil hoch)(pfeil hoch)5(pfeil hoch)s markierte 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung
US4954436A (en) * 1987-08-06 1990-09-04 Trustees Of Dartmouth College Dihydropyridine-sensitive calcium channel as a tumor associated marker
DE4224901A1 (de) * 1992-07-28 1994-02-03 Peter Dr Junghans Anordnung und Verfahren zur Bestimmung des Nitrosierungspotentials in einem biochemischen Reaktionssystem mittels der stabilisotopen ·1··5·N-Markierungstechnik
US5372813A (en) * 1992-12-22 1994-12-13 The Regents, University Of California Substituted 6-nitroquipazines, methods of preparation, and methods of use
JP3407888B2 (ja) * 1994-08-29 2003-05-19 メルシャン株式会社 １，４−ジヒドロピリジン誘導体
TW200519091A (en) * 2003-09-10 2005-06-16 Synta Pharmaceuticals Corp Dihydropyridine compounds for treating or preventing metabolic disorders
JP4952504B2 (ja) * 2007-10-17 2012-06-13 トヨタ自動車株式会社 減圧弁
CN109020875B (zh) * 2018-08-27 2020-05-22 北京市药品检验所 二氢吡啶类化合物脱氢芳构化方法及在药品检测中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2739922A1 (de) * 1977-09-05 1979-03-08 Max Planck Gesellschaft Penicillansaeurederivate, verfahren zu ihrer herstellung und ihre verwendung

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63162409U (2) * 1987-04-13 1988-10-24
JPH0476212U (2) * 1990-11-16 1992-07-03

Also Published As

Publication number Publication date
US4784958A (en) 1988-11-15
JPS60123470A (ja) 1985-07-02
DE3341806C2 (de) 1987-01-08
DE3341806A1 (de) 1985-05-30
GB8429054D0 (en) 1984-12-27
FR2555175B1 (fr) 1987-06-05
GB2150137A (en) 1985-06-26
GB2150137B (en) 1987-04-15
FR2555175A1 (fr) 1985-05-24

Similar Documents

Publication Publication Date Title
Wang et al. Enantioenrichment by crystallization
CN1642580B (zh) 放射性标记的喹啉和喹啉酮衍生物及其作为代谢性谷氨酸受体配体的制造用途
Glossmann et al. [42] Assay for calcium channels
US6221335B1 (en) Method of using deuterated calcium channel blockers
US4798897A (en) Isoquinoline derivatives
JPS6224423B2 (2)
Kirkovsky et al. Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring
EP0343961A2 (en) Aryl- and heteroaryl piperazinyl carboxamides having central nervous system activity
Fisher et al. Non-Peptide RGD Surrogates Which Mimic a Gly-Asp β-Turn: Potent Antagonists of Platelet Glycoprotein IIb− IIIa
Giardinà et al. Synthesis and biological profile of the enantiomers of [4-(4-amino-6, 7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin-1-yl] furan-2-ylmethanone (cyclazosin), a potent competitive α1B-adrenoceptor antagonist
Rovnyak et al. Studies directed toward ascertaining the active conformation of 1, 4-dihydropyridine calcium entry blockers
Boegesoe et al. Antihypertensive activity in a series of 1-piperazino-3-phenylindans with potent 5-HT2-antagonistic activity
SE445219B (sv) 1,4-dihydropyridinderivat, forfarande for framstellning derav samt farmaceutisk komposition
JPH0347168A (ja) ピペリジン誘導体
JPH0794417B2 (ja) Ｎ−アミノブチル−ｎ−フェニルアリールアミド誘導体
Shan et al. Syntheses, Calcium Channel Agonist− Antagonist Modulation Activities, Nitric Oxide Release, and Voltage-Clamp Studies of 2-Nitrooxyethyl 1, 4-Dihydro-2, 6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl) pyridine-5-carboxylate Enantiomers
Grunewald et al. Synthesis, Biochemical Evaluation, and Classical and Three-Dimensional Quantitative Structure− Activity Relationship Studies of 7-Substituted-1, 2, 3, 4-tetrahydroisoquinolines and Their Relative Affinities toward Phenylethanolamine N-Methyltransferase and the α2-Adrenoceptor, 1
US20030082665A1 (en) Fluorescence polarization assay
Levy et al. Development of a multigram asymmetric synthesis of 2-(R)-2-(4, 7, 10-tris tert-butylcarboxymethyl-1, 4, 7, 10-tetraazacyclododec-1-yl)-pentanedioic acid, 1-tert-butyl ester,(R)-tert-Bu4-DOTAGA
Henriksen et al. Syntheses, biological evaluation, and molecular modeling of 18F-labeled 4-anilidopiperidines as μ-opioid receptor imaging agents
JP3257677B2 (ja) ４−アミノ−ｎ−（４−メチル−４−ピペリジニル）−２−メトキシベンズアミド類
Qiu et al. Synthesis and in vitro evaluation of novel compounds and discovery of a promising iodine-125 radioligand for purinergic P2X7 receptor (P2X7R)
Skaddan et al. Synthesis, 18F-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptors
Wade et al. Application of base cleavable safety catch linkers to solid phase library production
US4794187A (en) 35 S-labelled 1.4-dihydropyridines